Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).

Détails

ID Serval
serval:BIB_34C8FF7B1FE5
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Périodique
Clinical Neurophysiology
Auteur(s)
Lefaucheur J.P., André-Obadia N., Antal A., Ayache S.S., Baeken C., Benninger D.H., Cantello R.M., Cincotta M., de Carvalho M., De Ridder D., Devanne H., Di Lazzaro V., Filipović S.R., Hummel F.C., Jääskeläinen S.K., Kimiskidis V.K., Koch G., Langguth B., Nyffeler T., Oliviero A., Padberg F., Poulet E., Rossi S., Rossini P.M., Rothwell J.C., Schönfeldt-Lecuona C., Siebner H.R., Slotema C.W., Stagg C.J., Valls-Sole J., Ziemann U., Paulus W., Garcia-Larrea L.
ISSN
1872-8952 (Electronic)
ISSN-L
1388-2457
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
125
Numéro
11
Pages
2150-2206
Langue
anglais
Notes
Publication types: review
Résumé
A group of European experts was commissioned to establish guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until March 2014, regarding pain, movement disorders, stroke, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, consciousness disorders, tinnitus, depression, anxiety disorders, obsessive-compulsive disorder, schizophrenia, craving/addiction, and conversion. Despite unavoidable inhomogeneities, there is a sufficient body of evidence to accept with level A (definite efficacy) the analgesic effect of high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the pain and the antidepressant effect of HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC). A Level B recommendation (probable efficacy) is proposed for the antidepressant effect of low-frequency (LF) rTMS of the right DLPFC, HF-rTMS of the left DLPFC for the negative symptoms of schizophrenia, and LF-rTMS of contralesional M1 in chronic motor stroke. The effects of rTMS in a number of indications reach level C (possible efficacy), including LF-rTMS of the left temporoparietal cortex in tinnitus and auditory hallucinations. It remains to determine how to optimize rTMS protocols and techniques to give them relevance in routine clinical practice. In addition, professionals carrying out rTMS protocols should undergo rigorous training to ensure the quality of the technical realization, guarantee the proper care of patients, and maximize the chances of success. Under these conditions, the therapeutic use of rTMS should be able to develop in the coming years.
Pubmed
Web of science
Création de la notice
27/12/2014 10:31
Dernière modification de la notice
20/08/2019 14:21
Données d'usage